DX-2930
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DX-2930, covering 2016-08-01 to 2018-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE [Phase 3]